Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. Medical Breakthroughs from Penn Medicine

Hepatitis C Virus (HCV): Current Screening Guidelines and Treatment Approaches

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    In 2014, the CDC estimated a total of 2,194 cases of acute hepatitis across 40 states and estimates that 2.7-3.9 million people in the United States have chronic hepatitis C.  Of every 100 persons affected by the disease, 75 to 85 will go on to develop chronic infection, 60 to 70 will go on to develop chronic liver disease, 5 to 20 will go on to develop cirrhosis over a period of 20–30 years, and 1 to 5 will die from the consequences of chronic infection (liver cancer or cirrhosis).  

    Joining our host, Dr. Jennifer Caudle, is Dr. Vincent Lo Re, Assistant Professor of Medicine and Infectious Diseases and Epidemiology at Penn Medicine. Dr. Lo Re discusses the current screening guidelines and recommendations regarding hepatitis C, long-term patient care, and the current landscape of treatment options. 

Recommended
Details
Presenters
Related
Comments
  • Sponsored by

  • Overview

    In 2014, the CDC estimated a total of 2,194 cases of acute hepatitis across 40 states and estimates that 2.7-3.9 million people in the United States have chronic hepatitis C.  Of every 100 persons affected by the disease, 75 to 85 will go on to develop chronic infection, 60 to 70 will go on to develop chronic liver disease, 5 to 20 will go on to develop cirrhosis over a period of 20–30 years, and 1 to 5 will die from the consequences of chronic infection (liver cancer or cirrhosis).  

    Joining our host, Dr. Jennifer Caudle, is Dr. Vincent Lo Re, Assistant Professor of Medicine and Infectious Diseases and Epidemiology at Penn Medicine. Dr. Lo Re discusses the current screening guidelines and recommendations regarding hepatitis C, long-term patient care, and the current landscape of treatment options. 

Schedule15 Dec 2024